메뉴 건너뛰기




Volumn 33, Issue 9, 2014, Pages 1341-1346

New gout test: Enhanced ex vivo cytokine production from PBMCS in common gout patients and a gout patient with Kearns-Sayre syndrome

Author keywords

Benzbromarone; Cytokine production; Ex vivo cell test; Febuxostat; Gout; Kearns Sayre syndrome; MSU crystal properties; PBMC; Screen test

Indexed keywords

ALLOPURINOL; BENZBROMARONE; C REACTIVE PROTEIN; CREATININE; DIURETIC AGENT; DNA DIRECTED DNA POLYMERASE GAMMA; FEBUXOSTAT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; PALMITIC ACID; PALMITOYL 3 CYSTEINE; PURINE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; URATE; CYTOKINE; URIC ACID;

EID: 84906352910     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2620-4     Document Type: Article
Times cited : (9)

References (8)
  • 1
    • 84867404142 scopus 로고    scopus 로고
    • Gout: Why is this curable disease so seldom cured?
    • Doherty M, Jansen TL, Nuki G et al (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71(11):1765-70
    • (2012) Ann Rheum Dis , vol.71 , Issue.11 , pp. 1765-1770
    • Doherty, M.1    Jansen, T.L.2    Nuki, G.3
  • 2
    • 84863199624 scopus 로고    scopus 로고
    • Enhanced interleukin-1beta production of PBMCs from patients with gout after stimulation with toll-like receptor-2 ligands and urate crystals
    • doi:10.1186/ar3898
    • Mylona EE, Mouktaroudi M, Crisan T et al (2012) Enhanced interleukin-1beta production of PBMCs from patients with gout after stimulation with toll-like receptor-2 ligands and urate crystals. Arthritis Res Ther 14:R158. doi:10.1186/ar3898
    • (2012) Arthritis Res Ther , vol.14
    • Mylona, E.E.1    Mouktaroudi, M.2    Crisan, T.3
  • 3
    • 84891683132 scopus 로고    scopus 로고
    • Febuxostat for the treatment of hyperuricaemia in people with gout: A single technology appraisal
    • doi:10.3310/hta13suppl3/06
    • Stevenson M, Pandor 2009 Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. Health Technol Assess; Suppl 3: 37-42. doi:10.3310/hta13suppl3/06
    • (2009) Health Technol Assess , Issue.SUPPL. 3 , pp. 37-42
    • Stevenson, M.P.1
  • 6
    • 84869111149 scopus 로고    scopus 로고
    • Fractional clearance of urate: Validation of measurement in spoturine samples in healthy subjects and gouty patients
    • Kannangara DRW, Ramasamy SN, Indraratna PL et al (2012) Fractional clearance of urate: validation of measurement in spoturine samples in healthy subjects and gouty patients. Arthritis Res & Ther 14:R189
    • (2012) Arthritis Res & Ther , vol.14
    • Kannangara, D.R.W.1    Ramasamy, S.N.2    Indraratna, P.L.3
  • 7
    • 34547623014 scopus 로고    scopus 로고
    • Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients
    • DOI 10.1007/s10067-006-0528-3
    • Reinders MK, Van Roon EN, Houtman PM, Brouwers JRBJ, Jansen TL (2007) Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients. Clin Rheumatol 26(9):1459-1465 (Pubitemid 47201684)
    • (2007) Clinical Rheumatology , vol.26 , Issue.9 , pp. 1459-1465
    • Reinders, M.K.1    Van Roon, E.N.2    Houtman, P.M.3    Brouwers, J.R.B.J.4    Jansen, T.L.Th.A.5
  • 8
    • 84902502296 scopus 로고    scopus 로고
    • Pharmacodynamic, pharmacokinetic and safety evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricemia
    • [Epub ahead of print] PMID 24509406
    • Fleishmann R, Kerr B, Yeh L-T, et al 2014 Pharmacodynamic, pharmacokinetic and safety evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricemia. Rheumatology [Epub ahead of print] PMID 24509406
    • (2014) Rheumatology
    • Fleishmann, R.1    Kerr, B.2    Yeh, L.-T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.